Medicure Inc. (CVE:MPH – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of C$0.89 and traded as low as C$0.72. Medicure shares last traded at C$0.89, with a volume of 6,996 shares changing hands.
Medicure Stock Up 18.7 %
The company has a market cap of C$9.29 million, a P/E ratio of -4.57 and a beta of 0.90. The company’s 50-day moving average is C$0.80 and its two-hundred day moving average is C$0.88. The company has a debt-to-equity ratio of 4.65, a current ratio of 2.03 and a quick ratio of 1.29.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
See Also
- Five stocks we like better than Medicure
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- Profitably Trade Stocks at 52-Week Highs
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- ESG Stocks, What Investors Should Know
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
